Atomistry » Fluorine » PDB 5ug8-5uv1 » 5uuu
Atomistry »
  Fluorine »
    PDB 5ug8-5uv1 »
      5uuu »

Fluorine in PDB 5uuu: Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure

Enzymatic activity of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure

All present enzymatic activity of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure:
2.7.11.15;

Protein crystallography data

The structure of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure, PDB code: 5uuu was solved by I.D.Hoffman, J.D.Lawson, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.00 / 2.70
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 126.180, 126.180, 96.369, 90.00, 90.00, 120.00
R / Rfree (%) 21.3 / 25.7

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure (pdb code 5uuu). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure, PDB code: 5uuu:
Jump to Fluorine binding site number: 1; 2; 3; 4; 5; 6;

Fluorine binding site 1 out of 6 in 5uuu

Go back to Fluorine Binding Sites List in 5uuu
Fluorine binding site 1 out of 6 in the Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:64.5
occ:0.50
 F32 A:QRW601 0.0 64.5 0.5
C31 A:QRW601 1.4 71.0 0.5
F33 A:QRW601 2.3 70.7 0.5
F34 A:QRW601 2.3 74.2 0.5
C26 A:QRW601 2.4 72.4 0.5
C30 A:QRW601 2.6 71.4 0.5
C27 A:QRW601 2.7 73.5 0.5
OE2 A:GLU239 2.9 66.2 1.0
O A:LEU235 3.0 59.3 1.0
C29 A:QRW601 3.1 72.3 0.5
CB A:GLU239 3.3 60.3 1.0
C A:LEU235 3.5 58.6 1.0
CA A:ALA236 3.6 56.8 1.0
C25 A:QRW601 3.6 71.2 0.5
C25 A:QRW601 3.7 69.3 0.5
O A:HOH707 3.8 46.5 1.0
N A:ALA236 3.8 56.8 1.0
CD A:GLU239 3.8 62.3 1.0
CA A:GLY337 4.0 56.3 1.0
CG A:GLU239 4.0 61.6 1.0
C28 A:QRW601 4.1 75.6 0.5
C24 A:QRW601 4.1 65.0 0.5
C24 A:QRW601 4.1 66.2 0.5
O A:ALA236 4.4 56.7 1.0
C A:ALA236 4.4 57.7 1.0
N A:GLU239 4.4 59.9 1.0
CA A:GLU239 4.5 59.7 1.0
C28 A:QRW601 4.5 73.8 0.5
CB A:LEU235 4.5 62.9 1.0
CD1 A:LEU222 4.6 53.6 1.0
CB A:ALA236 4.6 57.7 1.0
CA A:LEU235 4.6 61.5 1.0
N23 A:QRW601 4.7 60.3 1.0
C30 A:QRW601 4.7 74.4 0.5
O A:GLY337 4.9 64.4 1.0
N A:GLY337 4.9 55.2 1.0
C26 A:QRW601 4.9 71.2 0.5
C29 A:QRW601 4.9 76.0 0.5
C A:GLY337 5.0 57.9 1.0
OE1 A:GLU239 5.0 63.3 1.0

Fluorine binding site 2 out of 6 in 5uuu

Go back to Fluorine Binding Sites List in 5uuu
Fluorine binding site 2 out of 6 in the Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:70.6
occ:0.50
 F32 A:QRW601 0.0 70.6 0.5
C31 A:QRW601 1.4 71.8 0.5
F34 A:QRW601 2.3 71.0 0.5
F33 A:QRW601 2.3 75.6 0.5
C26 A:QRW601 2.4 71.2 0.5
C30 A:QRW601 2.6 74.4 0.5
C27 A:QRW601 2.6 72.9 0.5
C29 A:QRW601 3.0 76.0 0.5
O A:HOH732 3.5 67.6 1.0
C25 A:QRW601 3.7 69.3 0.5
C25 A:QRW601 3.8 71.2 0.5
C28 A:QRW601 4.0 73.8 0.5
C24 A:QRW601 4.3 66.2 0.5
C24 A:QRW601 4.3 65.0 0.5
C28 A:QRW601 4.4 75.6 0.5
N A:GLY201 4.7 68.7 1.0
C30 A:QRW601 4.7 71.4 0.5
CA A:GLY201 4.8 69.3 1.0
N23 A:QRW601 4.8 60.3 1.0
C29 A:QRW601 4.9 72.3 0.5
C26 A:QRW601 4.9 72.4 0.5

Fluorine binding site 3 out of 6 in 5uuu

Go back to Fluorine Binding Sites List in 5uuu
Fluorine binding site 3 out of 6 in the Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:70.7
occ:0.50
 F33 A:QRW601 0.0 70.7 0.5
C31 A:QRW601 1.4 71.0 0.5
F34 A:QRW601 2.3 74.2 0.5
F32 A:QRW601 2.3 64.5 0.5
C26 A:QRW601 2.4 72.4 0.5
C24 A:QRW601 2.4 65.0 0.5
C24 A:QRW601 2.5 66.2 0.5
C30 A:QRW601 2.6 71.4 0.5
N23 A:QRW601 2.7 60.3 1.0
C25 A:QRW601 2.8 71.2 0.5
O A:HOH707 2.9 46.5 1.0
C25 A:QRW601 2.9 69.3 0.5
OE2 A:GLU239 3.1 66.2 1.0
CD1 A:LEU222 3.2 53.6 1.0
C27 A:QRW601 3.6 73.5 0.5
C21 A:QRW601 3.7 57.9 1.0
C29 A:QRW601 3.8 72.3 0.5
CD2 A:LEU222 4.0 51.8 1.0
C30 A:QRW601 4.1 74.4 0.5
O22 A:QRW601 4.2 61.5 1.0
CD2 A:PHE202 4.2 65.8 1.0
CG A:LEU222 4.2 53.0 1.0
C26 A:QRW601 4.3 71.2 0.5
CD A:GLU239 4.3 62.3 1.0
CE A:LYS220 4.5 55.3 1.0
C19 A:QRW601 4.6 51.8 1.0
CA A:ALA236 4.7 56.8 1.0
C28 A:QRW601 4.7 75.6 0.5
CE2 A:PHE202 4.7 64.8 1.0
NZ A:LYS220 4.9 57.6 1.0
C29 A:QRW601 4.9 76.0 0.5
CB A:GLU239 4.9 60.3 1.0
C28 A:QRW601 5.0 73.8 0.5

Fluorine binding site 4 out of 6 in 5uuu

Go back to Fluorine Binding Sites List in 5uuu
Fluorine binding site 4 out of 6 in the Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:75.6
occ:0.50
 F33 A:QRW601 0.0 75.6 0.5
C31 A:QRW601 1.4 71.8 0.5
F34 A:QRW601 2.3 71.0 0.5
F32 A:QRW601 2.3 70.6 0.5
C26 A:QRW601 2.4 71.2 0.5
C30 A:QRW601 2.9 74.4 0.5
C25 A:QRW601 3.1 69.3 0.5
CE1 A:PHE202 3.2 69.5 1.0
C24 A:QRW601 3.2 66.2 0.5
C24 A:QRW601 3.2 65.0 0.5
C25 A:QRW601 3.2 71.2 0.5
CZ A:PHE202 3.3 67.3 1.0
C27 A:QRW601 3.3 72.9 0.5
CD1 A:PHE202 3.4 69.0 1.0
CE2 A:PHE202 3.6 64.8 1.0
CG A:PHE202 3.7 67.2 1.0
CD2 A:PHE202 3.8 65.8 1.0
C29 A:QRW601 3.8 76.0 0.5
CA A:GLY201 3.8 69.3 1.0
N A:PHE202 3.9 67.4 1.0
N23 A:QRW601 4.1 60.3 1.0
N A:GLY201 4.1 68.7 1.0
C A:GLY201 4.1 69.1 1.0
C30 A:QRW601 4.3 71.4 0.5
C26 A:QRW601 4.4 72.4 0.5
O22 A:QRW601 4.5 61.5 1.0
C28 A:QRW601 4.5 73.8 0.5
CB A:PHE202 4.6 67.1 1.0
C21 A:QRW601 4.7 57.9 1.0
O A:HOH732 4.7 67.6 1.0
C28 A:QRW601 4.8 75.6 0.5
CA A:PHE202 4.9 67.6 1.0
C29 A:QRW601 4.9 72.3 0.5

Fluorine binding site 5 out of 6 in 5uuu

Go back to Fluorine Binding Sites List in 5uuu
Fluorine binding site 5 out of 6 in the Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 5 of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:74.2
occ:0.50
 F34 A:QRW601 0.0 74.2 0.5
C31 A:QRW601 1.4 71.0 0.5
F33 A:QRW601 2.3 70.7 0.5
F32 A:QRW601 2.3 64.5 0.5
C26 A:QRW601 2.4 72.4 0.5
C30 A:QRW601 2.6 71.4 0.5
C25 A:QRW601 3.1 71.2 0.5
CD2 A:PHE202 3.1 65.8 1.0
C25 A:QRW601 3.1 69.3 0.5
CE2 A:PHE202 3.2 64.8 1.0
C24 A:QRW601 3.2 65.0 0.5
C24 A:QRW601 3.2 66.2 0.5
N A:ALA236 3.2 56.8 1.0
CA A:ALA236 3.2 56.8 1.0
C27 A:QRW601 3.3 73.5 0.5
C29 A:QRW601 3.5 72.3 0.5
C A:LEU235 3.5 58.6 1.0
CB A:ALA236 3.6 57.7 1.0
O A:LEU235 3.8 59.3 1.0
CB A:LEU235 3.8 62.9 1.0
CD1 A:LEU222 3.9 53.6 1.0
C26 A:QRW601 4.3 71.2 0.5
N23 A:QRW601 4.3 60.3 1.0
C30 A:QRW601 4.3 74.4 0.5
CA A:LEU235 4.4 61.5 1.0
CG A:PHE202 4.4 67.2 1.0
C28 A:QRW601 4.4 75.6 0.5
O A:GLY232 4.5 56.2 1.0
CZ A:PHE202 4.5 67.3 1.0
C28 A:QRW601 4.6 73.8 0.5
C A:ALA236 4.6 57.7 1.0
OE2 A:GLU239 4.7 66.2 1.0
O A:HOH707 4.8 46.5 1.0
C27 A:QRW601 4.9 72.9 0.5
C29 A:QRW601 4.9 76.0 0.5

Fluorine binding site 6 out of 6 in 5uuu

Go back to Fluorine Binding Sites List in 5uuu
Fluorine binding site 6 out of 6 in the Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 6 of Design, Synthesis, and Evaluation of the First Selective and Potent G- Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F601

b:71.0
occ:0.50
 F34 A:QRW601 0.0 71.0 0.5
C31 A:QRW601 1.4 71.8 0.5
F33 A:QRW601 2.3 75.6 0.5
F32 A:QRW601 2.3 70.6 0.5
C26 A:QRW601 2.4 71.2 0.5
C30 A:QRW601 2.4 74.4 0.5
O A:HOH732 2.7 67.6 1.0
C24 A:QRW601 2.7 66.2 0.5
C24 A:QRW601 2.8 65.0 0.5
N23 A:QRW601 2.8 60.3 1.0
C25 A:QRW601 2.9 69.3 0.5
C25 A:QRW601 3.0 71.2 0.5
N A:GLY201 3.2 68.7 1.0
C21 A:QRW601 3.2 57.9 1.0
O22 A:QRW601 3.5 61.5 1.0
C27 A:QRW601 3.5 72.9 0.5
C29 A:QRW601 3.6 76.0 0.5
CA A:GLY201 3.7 69.3 1.0
C19 A:QRW601 4.1 51.8 1.0
N A:PHE202 4.2 67.4 1.0
C A:GLY200 4.2 68.3 1.0
C30 A:QRW601 4.2 71.4 0.5
C20 A:QRW601 4.3 48.6 1.0
C26 A:QRW601 4.3 72.4 0.5
CA A:GLY200 4.4 63.9 1.0
C A:GLY201 4.5 69.1 1.0
C28 A:QRW601 4.7 73.8 0.5
C28 A:QRW601 4.8 75.6 0.5
CG A:PHE202 4.9 67.2 1.0
O A:HOH707 4.9 46.5 1.0
C29 A:QRW601 4.9 72.3 0.5

Reference:

T.Okawa, Y.Aramaki, M.Yamamoto, T.Kobayashi, S.Fukumoto, Y.Toyoda, T.Henta, A.Hata, S.Ikeda, M.Kaneko, I.D.Hoffman, B.C.Sang, H.Zou, T.Kawamoto. Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor For the Potential Treatment of Heart Failure. J. Med. Chem. V. 60 6942 2017.
ISSN: ISSN 1520-4804
PubMed: 28699740
DOI: 10.1021/ACS.JMEDCHEM.7B00443
Page generated: Thu Aug 1 15:47:14 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy